Compare DGX & CHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGX | CHD |
|---|---|---|
| Founded | 1967 | 1846 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 23.6B |
| IPO Year | 1996 | 2014 |
| Metric | DGX | CHD |
|---|---|---|
| Price | $242.34 | $105.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 21 |
| Target Price | ★ $251.40 | $104.63 |
| AVG Volume (30 Days) | 791.2K | ★ 1.3M |
| Earning Date | 10-22-2026 | 10-30-2026 |
| Dividend Yield | ★ 1.41% | 1.13% |
| EPS Growth | 13.78 | ★ 27.43 |
| EPS | ★ 5.08 | 1.76 |
| Revenue | ★ $11,035,000,000.00 | $6,203,200,000.00 |
| Revenue This Year | $8.86 | $0.61 |
| Revenue Next Year | $4.58 | $4.28 |
| P/E Ratio | ★ $47.99 | $61.72 |
| Revenue Growth | ★ 11.78 | 1.57 |
| 52 Week Low | $171.18 | $81.33 |
| 52 Week High | $248.84 | $108.79 |
| Indicator | DGX | CHD |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 63.94 |
| Support Level | $228.47 | $92.49 |
| Resistance Level | $248.02 | $106.04 |
| Average True Range (ATR) | 6.41 | 2.00 |
| MACD | 1.31 | 0.89 |
| Stochastic Oscillator | 83.02 | 72.24 |
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. The firm also added Touchland and its hand sanitizer business to its fold in fiscal 2025. Even as it expands its product reach, Church & Dwight still derives around 80% of its sales from its home US market.